Robert Francomano - Net Worth and Insider Trading
Robert Francomano Net Worth
The estimated net worth of Robert Francomano is at least $2 Million dollars as of 2024-12-27. Robert Francomano is the Chief Commercial Officer of Stemline Therapeutics Inc and owns about 197,658 shares of Stemline Therapeutics Inc (STML) stock worth over $2 Million. Details can be seen in Robert Francomano's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Francomano has not made any transactions after 2020-05-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Francomano
Robert Francomano Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Francomano owns 1 companies in total, including SELLAS Life Sciences Group Inc (SLS) .
Click here to see the complete history of Robert Francomano’s form 4 insider trades.
Insider Ownership Summary of Robert Francomano
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SLS | SELLAS Life Sciences Group Inc | 2022-03-14 | Chief Commercial Officer |
Robert Francomano Latest Holdings Summary
Robert Francomano currently owns a total of 1 stock. Robert Francomano owns 197,658 shares of Stemline Therapeutics Inc (STML) as of May 4, 2020, with a value of $2 Million.
Latest Holdings of Robert Francomano
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| STML | Stemline Therapeutics Inc | 2020-05-04 | 197,658 | 11.83 | 2,338,294 |
Holding Weightings of Robert Francomano
Robert Francomano Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Francomano has made a total of 3 transactions in Stemline Therapeutics Inc (STML) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Stemline Therapeutics Inc is the sale of 272 shares on May 4, 2020, which brought Robert Francomano around $3,131.
Insider Trading History of Robert Francomano
- 1
Robert Francomano Trading Performance
Robert Francomano Ownership Network
Robert Francomano Owned Company Details
What does SELLAS Life Sciences Group Inc do?
Who are the key executives at SELLAS Life Sciences Group Inc?
Robert Francomano is the Chief Commercial Officer of SELLAS Life Sciences Group Inc. Other key executives at SELLAS Life Sciences Group Inc include EVP & Gen. Counsel & Corp. Sec. Barbara A Wood , VP & Finance & Corp Controller John Thomas Burns , and director & President and CEO Angelos M. Stergiou .
SELLAS Life Sciences Group Inc (SLS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of SELLAS Life Sciences Group Inc (SLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SELLAS Life Sciences Group Inc (SLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
SELLAS Life Sciences Group Inc (SLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
SELLAS Life Sciences Group Inc Insider Transactions
Robert Francomano Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Francomano. You might contact Robert Francomano via mailing address: C/o Stemline Therapeutics, Inc., 750 Lexington Avenue, 11th Floor, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
